TransMedics (TMDX) Cash from Operations (2018 - 2026)

TransMedics has reported Cash from Operations for 9 years, with the latest figure at 24533000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 959.3% year-over-year to 24533000.0; the trailing twelve-month figure through Mar 2026 stood at 220228000.0 (up 345.96% YoY), and the FY2025 full-year result was 192840000.0, up 295.14% from the prior year.
• Cash from Operations for Q1 2026 stood at 24533000.0, down from 34513000.0 in the prior quarter.
• The five-year high for Cash from Operations was 91609000.0 in Q2 2025, with the low at 18406000.0 in Q1 2022.
• Average Cash from Operations over 5 years is 12195941.18, with a median of 2855000.0 recorded in 2025.
• Year-over-year, Cash from Operations plunged 151.11% in 2022 and soared 959.3% in 2026.
• Tracing TMDX's Cash from Operations over 5 years: stood at 4035000.0 in 2022, then jumped by 305.8% to 8304000.0 in 2023, then jumped by 136.79% to 19663000.0 in 2024, then surged by 75.52% to 34513000.0 in 2025, then decreased by 28.92% to 24533000.0 in 2026.
• The last three Cash from Operations figures came in at 24533000.0 (Q1 2026), 34513000.0 (Q4 2025), and 69573000.0 (Q3 2025), per Business Quant data.

Peer Comparison